PIII
P3 Health Partners Inc.
NasdaqCMUSDEQUITY
Healthcare
DELAYED
Last price
10.01
▼ 0.22 (2.15%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Tool
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
10.23
Prev close
10.23
Day high
10.39
Day low
10.08
Volume
7.00K
Market cap
$2.06B
P/E (TTM)
—
52W range
1.52 – 16.89
Day trading desk
Gap from prior close
-1.02%
Prior close 10.34
VWAP
10.20
-1.84% from price
Relative volume
0.08×
Quiet session
Session range
3.76%
10.01 – 10.39
Position in range
0%
Near session low
ATR (14D)
1.01
10.09% of price
Prior day high
10.56
PDH
Prior day low
9.95
PDL
Bid / ask spread
—
Quote not published
Session volume
5.71K
Avg 67.28K
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Returnvs SPY
1W
-3.51%
-2.1%
1M
+10.74%
+7.0%
3M
-25.61%
-28.7%
6M
+381.78%
+370.7%
YTD
+195.42%
+183.1%
1Y
+40.94%
+20.9%
3Y
-87.94%
-162.1%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on PIII open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
+100.00K
Net buying
Buy transactions
2
150.00K shares
Sell transactions
1
50.00K shares
Net transactions
+3
Buys less sells
Sell : buy shares
0.3 : 1
Mixed
Insider-held shares
1.89M
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Sep 13, 24 | CHICAGO PACIFIC FOUNDERS UGP III, L.L.C. Beneficial Owner of more than 10% of a Class of Security |
BUY | 160.00K | $81.55K | Indirect |
| Sep 11, 24 | CHICAGO PACIFIC FOUNDERS UGP III, L.L.C. Beneficial Owner of more than 10% of a Class of Security |
BUY | 240.00K | $128.62K | Indirect |
| Sep 6, 24 | CHICAGO PACIFIC FOUNDERS UGP III, L.L.C. Beneficial Owner of more than 10% of a Class of Security |
BUY | 240.00K | $117.54K | Indirect |
| May 24, 24 | LEAVITT LEGACY, L.L.C Beneficial Owner of more than 10% of a Class of Security |
BUY | 7.97M | $4.70M | Indirect |
| Oct 23, 23 | TOLAN MARY A Director |
STOCK | 216.56K | $0 | Direct |
| Oct 23, 23 | WASSON GREGORY D Director |
STOCK | 216.56K | $0 | Direct |
| Oct 23, 23 | THIERER MARK ALAN Director |
STOCK | 433.12K | $0 | Direct |
| Oct 23, 23 | PARK JEFFREY G Director |
STOCK | 216.56K | $0 | Direct |
| Oct 23, 23 | KAZARIAN GREGORY N Director |
STOCK | 216.56K | $0 | Direct |
| Oct 23, 23 | LEISURE LAWRENCE B. Director |
STOCK | 216.56K | $0 | Direct |
| Oct 23, 23 | PRICE THOMAS EDMUNDS Director |
STOCK | 216.56K | $0 | Direct |
| Sep 14, 23 | CHICAGO PACIFIC FOUNDERS UGP III, L.L.C. Beneficial Owner of more than 10% of a Class of Security |
BUY | 90.00K | $227.14K | Indirect |
| Sep 13, 23 | CHICAGO PACIFIC FOUNDERS UGP III, L.L.C. Beneficial Owner of more than 10% of a Class of Security |
BUY | 270.00K | $684.96K | Indirect |
| Sep 13, 23 | CHICAGO PACIFIC FOUNDERS UGP III, L.L.C. Beneficial Owner of more than 10% of a Class of Security |
BUY | 270.00K | $684.96K | Indirect |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
BACCHUS AMIR |
Officer and Director | 2.26M | Stock Award(Grant) |
CHICAGO PACIFIC FOUNDERS UGP III, L.L.C. |
Beneficial Owner of more than 10% of a Class of Security | — | Purchase |
KAZARIAN GREGORY N |
Director | 216.56K | Stock Award(Grant) |
LEAVITT LEGACY, L.L.C |
Beneficial Owner of more than 10% of a Class of Security | — | Purchase |
LEISURE LAWRENCE B. |
Director | 216.56K | Stock Award(Grant) |
PARK JEFFREY G |
Director | 216.56K | Stock Award(Grant) |
PRICE THOMAS EDMUNDS |
Director | 216.56K | Stock Award(Grant) |
THIERER MARK ALAN |
Director | 859.13K | Stock Award(Grant) |
TOLAN MARY A |
Director | 216.56K | Stock Award(Grant) |
WASSON GREGORY D |
Director | 1.08M | Stock Award(Grant) |
Fundamentals
Market cap$2.06B
Enterprise value$379.64M
Revenue (TTM)$1.50B
Gross profit$70.59M
EBITDA$-64.48M
Net income$-108.01M
EPS (TTM)$-33.01
Free cash flow$-124.25M
Total cash$21.27M
Total debt$130.69M
Book value / share$-23.59
Shares outstanding3.91M
Float1.92M
Short % of float1.42%
Dividend yield—
Beta (5Y)1.64
Valuation & profitability ratios
Trailing P/E—
Forward P/E-49.10
PEG ratio—
Price / sales—
Price / book—
EV / revenue0.25
EV / EBITDA-5.89
Gross margin4.70%
Operating margin10.67%
Profit margin-6.55%
Return on equity-192.58%
Return on assets-13.40%
Debt / equity94.95
Current ratio0.46
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $1.46B | $1.50B | $1.27B | $1.05B | -2.8% |
| Operating revenue | $1.43B | $1.48B | $1.25B | $1.03B | -3.7% |
| Selling, general & admin | $107.23M | $113.93M | $125.59M | $162.38M | -5.9% |
| Total operating expense | $1.73B | $1.81B | $1.43B | $1.30B | -4.6% |
| Operating income | -$270.30M | -$312.60M | -$167.93M | -$245.96M | +13.5% |
| Net interest income | -$55.03M | -$22.17M | -$15.98M | -$11.40M | -148.2% |
| Pre-tax income | -$321.06M | -$305.99M | -$183.73M | -$1.56B | -4.9% |
| Tax provision | $2.02M | $4.39M | $2.69M | $1.86M | -53.8% |
| Net income | -$147.95M | -$135.85M | -$57.77M | -$270.13M | -8.9% |
| Net income to common | -$147.95M | -$135.85M | -$57.77M | -$270.13M | -8.9% |
| Basic EPS | -45.26 | -47.00 | -30.50 | -325.00 | +3.7% |
| Diluted EPS | -45.26 | -54.00 | -31.50 | -325.00 | +16.2% |
| EBIT | -$266.03M | -$283.82M | -$167.75M | -$1.55B | +6.3% |
| EBITDA | -$181.86M | -$197.76M | -$81.07M | -$1.46B | +8.0% |
| Basic shares | 3.27M | 2.90M | 1.90M | 832.00K | +12.6% |
| Diluted shares | 3.27M | 2.94M | 5.89M | 832.00K | +11.2% |
| Line item | 2025 | 2024 | 2023 | 2022 | 2021 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $25.01M | $38.82M | $36.32M | $17.54M | — | -35.6% |
| Cash & short-term investments | $25.01M | $38.82M | $36.32M | $17.54M | — | -35.6% |
| Accounts receivable | $92.46M | $121.27M | $118.50M | $72.09M | — | -23.8% |
| Total current assets | $133.08M | $184.14M | $166.02M | $100.69M | — | -27.7% |
| Property, plant & equipment | $3.37M | $5.73M | $8.69M | $8.84M | — | -41.2% |
| Goodwill & intangibles | $492.42M | $574.35M | $666.73M | $751.05M | — | -14.3% |
| Total assets | $656.64M | $783.42M | $860.97M | $876.57M | — | -16.2% |
| Total current liabilities | $545.26M | $496.42M | $299.37M | $241.66M | — | +9.8% |
| Current debt | $45.04M | $75.16M | — | — | $3.63M | -40.1% |
| Long-term debt | $228.37M | $108.91M | $108.32M | $94.42M | — | +109.7% |
| Total debt | $284.88M | $195.40M | $121.94M | $105.94M | — | +45.8% |
| Total liabilities | $796.88M | $633.89M | $427.31M | $353.91M | — | +25.7% |
| Retained earnings | -$651.14M | -$503.19M | -$367.34M | -$309.55M | — | -29.4% |
| Shareholder equity | -$155.23M | $75.94M | $142.13M | $5.85M | — | -304.4% |
| Working capital | -$412.17M | -$312.27M | -$133.35M | -$140.97M | — | -32.0% |
| Net tangible assets | -$647.65M | -$498.41M | -$524.60M | -$745.20M | — | -29.9% |
| Shares issued | 3.29M | 3.26M | 2.33M | 831.58K | — | +0.9% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | -$323.09M | -$310.38M | -$186.43M | -$1.56B | -4.1% |
| Depreciation & amortisation | $84.16M | $86.06M | $86.67M | $87.29M | -2.2% |
| Stock-based compensation | $5.58M | $5.75M | $5.98M | $19.40M | -3.0% |
| Change in working capital | $81.91M | $80.08M | $30.30M | $34.82M | +2.3% |
| Operating cash flow | -$91.24M | -$110.13M | -$76.03M | -$126.02M | +17.2% |
| Capital expenditure | — | — | -$1.83M | -$2.23M | — |
| Investing cash flow | $129.00K | $14.53M | -$1.83M | -$7.73M | -99.1% |
| Financing cash flow | $72.81M | $98.77M | $100.33M | $11.38M | -26.3% |
| Free cash flow | -$91.24M | -$110.13M | -$77.86M | -$128.25M | +17.2% |
| End cash position | $25.81M | $44.10M | $40.93M | $18.46M | -41.5% |
| Line item | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $386.39M | $384.81M | $345.25M | $355.79M | $373.23M | +0.4% |
| Operating revenue | $379.50M | $366.18M | $341.56M | $351.72M | $369.52M | +3.6% |
| Selling, general & admin | $25.77M | $36.21M | $22.39M | $23.45M | $25.18M | -28.8% |
| Total operating expense | $378.15M | $538.68M | $389.48M | $389.91M | $411.31M | -29.8% |
| Operating income | $8.24M | -$153.87M | -$44.22M | -$34.12M | -$38.09M | +105.4% |
| Net interest income | -$16.77M | -$15.64M | -$20.53M | -$10.14M | -$8.72M | -7.2% |
| Pre-tax income | -$7.96M | -$166.75M | -$69.45M | -$41.68M | -$43.17M | +95.2% |
| Tax provision | -$11.00M | -$1.04M | $11.00K | $1.98M | $1.07M | -957.4% |
| Net income | $1.22M | -$75.52M | -$31.59M | -$20.36M | -$20.48M | +101.6% |
| Net income to common | $1.22M | -$75.52M | -$31.59M | -$20.36M | -$20.48M | +101.6% |
| Basic EPS | 0.37 | -23.02 | -9.67 | -6.23 | -6.28 | +101.6% |
| Diluted EPS | 0.32 | -23.02 | -9.67 | -6.23 | -6.28 | +101.4% |
| EBIT | $8.81M | -$151.12M | -$48.92M | -$31.54M | -$34.45M | +105.8% |
| EBITDA | $29.88M | -$130.12M | -$27.89M | -$10.46M | -$13.40M | +123.0% |
| Basic shares | 3.29M | 3.28M | 3.27M | 3.27M | 3.26M | +0.2% |
| Diluted shares | 8.42M | 7.20M | 3.27M | 3.27M | 3.26M | +16.9% |
| Line item | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $25.50M | $25.01M | $37.71M | $38.58M | $40.08M | +1.9% |
| Cash & short-term investments | $25.50M | $25.01M | $37.71M | $38.58M | $40.08M | +1.9% |
| Accounts receivable | $124.89M | $92.46M | $82.02M | $93.46M | $129.35M | +35.1% |
| Total current assets | $172.21M | $133.08M | $135.63M | $156.53M | $191.44M | +29.4% |
| Property, plant & equipment | $2.96M | $3.37M | $3.90M | $4.69M | $5.31M | -12.2% |
| Goodwill & intangibles | $472.99M | $492.42M | $512.91M | $533.40M | $553.89M | -3.9% |
| Total assets | $674.16M | $656.64M | $683.56M | $731.59M | $783.87M | +2.7% |
| Total current liabilities | $525.49M | $545.26M | $423.95M | $505.00M | $507.03M | -3.6% |
| Current debt | $52.27M | $45.04M | $38.73M | $80.45M | $65.80M | +16.1% |
| Long-term debt | $259.57M | $228.37M | $214.18M | $101.96M | $106.12M | +13.7% |
| Total debt | $322.67M | $284.88M | $264.96M | $192.72M | $182.90M | +13.3% |
| Total liabilities | $807.32M | $796.88M | $664.64M | $644.41M | $662.79M | +1.3% |
| Retained earnings | -$649.92M | -$651.14M | -$575.62M | -$544.03M | -$523.67M | +0.2% |
| Shareholder equity | -$144.91M | -$155.23M | -$18.69M | $44.46M | $63.25M | +6.7% |
| Working capital | -$353.27M | -$412.17M | -$288.32M | -$348.47M | -$315.60M | +14.3% |
| Net tangible assets | -$617.90M | -$647.65M | -$531.60M | -$488.94M | -$490.64M | +4.6% |
| Shares issued | 3.29M | 3.29M | 3.27M | 3.27M | 3.26M | +0.2% |
| Line item | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|
| Net income | $3.04M | -$165.71M | -$69.46M | -$43.66M | -$44.25M | +101.8% |
| Depreciation & amortisation | $21.07M | $21.00M | $21.03M | $21.08M | $21.05M | +0.4% |
| Stock-based compensation | $1.05M | $1.10M | $1.21M | $1.46M | $1.81M | -4.4% |
| Change in working capital | -$61.67M | $49.78M | $21.87M | $18.00M | -$7.74M | -223.9% |
| Operating cash flow | -$27.47M | -$25.73M | -$15.41M | -$16.63M | -$33.47M | -6.8% |
| Investing cash flow | -$43.00K | $198.00K | -$119.00K | $50.00K | $0 | -121.7% |
| Financing cash flow | $27.80M | $12.87M | $14.67M | $14.62M | $30.66M | +116.0% |
| Free cash flow | -$27.47M | -$25.61M | -$15.53M | -$16.63M | -$33.47M | -7.3% |
| End cash position | $26.10M | $25.81M | $38.46M | $39.33M | $41.29M | +1.1% |
Options analytics
Put / call volume
—
—
Put / call open interest
—
Positioning, not flow
Max pain
—
—
ATM implied vol
—
Nearest strike to spot
Skew (10% OTM)
—
—
Call volume
0
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
—
—
Heaviest put OI
—
—
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jun 2026 | -1.90 | -0.63 | +66.8% |
| Dec 2025 | -9.47 | -23.02 | -143.2% |
| Sep 2025 | -6.04 | -9.67 | -60.2% |
| Jun 2025 | -4.30 | -6.23 | -44.9% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | -1.90 | 2 | $377.80M | +6.2% |
| Next quarter | -7.04 | 1 | $401.70M | +4.4% |
| Current year | -14.84 | 1 | $1.56B | +6.9% |
| Next year | -10.60 | 2 | $1.70B | +8.8% |
Analyst targets & ownership
Mean target$18.00
High target$23.00
Low target$13.00
Implied upside79.82%
Analyst count2
ConsensusBUY
Strong buy / Buy0 / 1
Hold1
Sell / Strong sell0 / 0
Held by insiders48.38%
Held by institutions8.24%
Institutions holding25
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
11.08
-9.65% from price
SMA 20
10.77
-4.26% from price
SMA 50
10.82
-4.69% from price
SMA 100
8.55
+17.05% from price
SMA 200
6.17
+67.01% from price
EMA 12
10.71
-6.51% from price
EMA 26
10.71
-6.51% from price
EMA 50
10.33
-3.14% from price
RSI (14)
46.3
Neutral
MACD (12,26,9)
0.00
Hist -0.10
ATR (14)
1.01
9.80% of price
Realised vol 30D
72.9%
Annualised
Bollinger upper
12.29
20, 2σ
Bollinger lower
9.25
20, 2σ
50 / 200 cross
Golden
10.82 vs 6.17
Trend bias
Above 200
+67.01%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
-1.54
Less volatile than market
Correlation to SPY
-0.09
Largely independent
Realised vol 30D
72.9%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-85.1%
Peak to trough
Max drawdown 5Y
-99.7%
Peak to trough
ATR 14
1.01
9.80% of price
Beta (reported)
1.64
5Y monthly, from filing
Short interest
Shares short
35.98K
Prior 48.84K
Change vs prior
-26.3%
Shorts covering
% of float
1.42%
Normal
% of shares out
1.08%
Against total outstanding
Days to cover
1.4
Liquid
Float
1.92M
Freely tradeable shares
Exchanges publish short interest twice a month with a settlement lag, so this is roughly two weeks behind. Days to cover divides shares short by average daily volume — it estimates how long covering would take, not whether it will happen.
Rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| May 22, 26 | TD Cowen | MAINTAINED | Hold | Hold |
| May 15, 26 | Lake Street | MAINTAINED | Buy | Buy |
| Apr 2, 26 | TD Cowen | MAINTAINED | Hold | Hold |
| Mar 27, 26 | Lake Street | MAINTAINED | Buy | Buy |
| Nov 17, 25 | Lake Street | MAINTAINED | Buy | Buy |
| Apr 21, 25 | Lake Street | MAINTAINED | Buy | Buy |
| Nov 20, 24 | TD Cowen | MAINTAINED | Hold | Hold |
| Apr 1, 24 | BTIG | DOWNGRADE | Buy | Neutral |
| Mar 14, 24 | Lake Street | MAINTAINED | Buy | Buy |
| Sep 1, 23 | BTIG | INITIATED | — | Buy |
| Jun 30, 23 | TD Cowen | INITIATED | — | Market Perform |
| Jan 4, 22 | William Blair | INITIATED | — | Outperform |
Dividends & splits
Forward rate—
Forward yield—
5-year avg yield—
Payout ratio0.00%
Ex-dividend date—
Next pay date—
Last split1:50
Split dateApr 14, 2025
SEC filings
Periodic Financial Reports
10-Q · 2026-08-10
Corporate Changes & Voting Matters
8-K · 2026-07-06
Corporate Changes & Voting Matters
8-K · 2026-06-10
Corporate Changes & Voting Matters
8-K · 2026-05-26
Corporate Changes & Voting Matters
8-K · 2026-05-15
Corporate Changes & Voting Matters
8-K · 2026-05-14
Proxy Statements
DEF 14A · 2026-04-30
Corporate Changes & Voting Matters
8-K · 2026-04-28
Headlines
P3 Health Partners (PIII) Q2 2026 Earnings Call Transcript
Motley Fool · 6d ago
P3 Health Partners Inc. Q2 2026 Earnings Call Summary
Moby · 12d ago
P3 Health Partners Q2 Earnings Call Highlights
MarketBeat · 13d ago
P3 Health Partners Announces Second Quarter 2026 Results
Business Wire · 13d ago
Earnings To Watch: P3 Health Partners Inc (PIII) Q2 2026 -- GF Value Sees 48% Downside
GuruFocus.com · 16d ago
P3 Health Partners Schedules Second Quarter 2026 Earnings Release and Conference Call
Business Wire · 33d ago
P3 Health Partners (PIII) Stock Sees Fair Value Lift After Strong EBITDA And Guidance
Simply Wall St. · 57d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.